Search Results for: HCV

October 13, 2014October 13, 2014

Burmans Specialty Pharmacy Awarded for Making HCV Drugs Accessible

Hepatitis C, News

A five-decade leader in the field of pharmaceutical marketing and distributorship, Burmans Specialty Pharmacy, has announced that it is the first recipient of the “Shaping Healthcare Delivery” award at the recently-concluded ... Read more

September 29, 2014September 29, 2014

Gilead’s HCV Combination Therapy Tablet Harvoni Gets Positive CHMP Opinion

Hepatitis C, News

The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has published a positive report on Gilead’s experimental once-daily dose of the combination therapy ... Read more

June 8, 2017August 24, 2022

WHO recommends Epclusa, a Hepatitis C Combined Therapy in Just One Pill

Hepatitis C, News

A combined treatment for hepatitis C based on sofosbuvir and velpatasvir (brand name Epclusa) is among the additions to the World Health Organization (WHO) Model List of Essential Medicines (EML) for 2017. ... Read more

June 6, 2017June 6, 2017

Sofosbuvir Reduces Transplant Need and Mortality Rates in Hepatitis C Patients, Study Finds

Hepatitis C, News

Sofosbuvir (sold under the brand name Sovaldi from Gilead Sciences, among others) significantly reduces the risk of death and the need for liver transplant in patients with hepatitis C who suffer from advanced stages ... Read more

June 1, 2017June 1, 2017

Survey Reports Gaps in Hepatitis Testing and Monitoring Across European Union

Hepatitis B, Hepatitis C, News

Results from a European Centre for Disease Prevention and Control (ECDC) survey suggest that European Union/European Economic Area (EU/EEA) member states suffer from significant gaps in national testing policies and ... Read more

May 25, 2017May 25, 2017

FDA Reviewing Application for Opdivo Use in Hepatocellular Carcinoma, Often Caused by Hepatitis

Hepatitis B, Hepatitis C, News

The U.S. Food and Drug Administration (FDA) recently accepted a supplemental Biologics License Application (sBLA) to extend the use of Opdivo (nivolumab) to patients with hepatocellular carcinoma (HCC). People chronically infected with hepatitis ... Read more

May 18, 2017May 18, 2017

17 US States’ High Hepatitis C Rates Are a Result of Public Policy Shortcomings, Report Says

Hepatitis C, News

Seventeen American states had high rates of Hepatitis C in 2015 because they lacked laws and Medicaid policies to prevent drug users from developing the disease, and obtaining treatment once ... Read more

May 16, 2017May 16, 2017

Patient-Centered Medical Home Care Approach Effective in Hepatitis C Treatment

Hepatitis C, News

Boston Medical Center eliminated the hepatitis C virus (HCV) in 66 patients it treated with a comprehensive care program that included doctors, pharmacists, pharmacy techs and social workers, according to a study. ... Read more

May 11, 2017May 11, 2017

Hepatitis C Hijacks Signaling-Pathway Proteins to Survive, Grow in the Body, Study Reports

Hepatitis C, News

The hepatitis C virus hijacks proteins involved in key signaling pathways to help it survive and grow in the body, according to Australian researchers who identified the proteins. New treatments ... Read more

May 2, 2017May 2, 2017

Doctors Transplant Kidneys with Hepatitis C, Then Cure Recipients’ Infection

Hepatitis C, News

Ten clinical trial participants were cured of hepatitis C after receiving a kidney transplant from deceased donors who were infected with the virus, according to a study led by Penn Medicine ... Read more